ImmunoPrecise, Mila partner on antibody therapeutics

By The Science Advisory Board staff writers

November 3, 2020 -- ImmunoPrecise Antibodies and artificial intelligence (AI) research institute Mila have formed a partnership to collaborate on research and talent development initiatives for antibody-based therapeutics.

Specifically, the partnership will apply AI to unexplored datasets generated by ImmunoPrecise's therapeutic antibody discovery platforms to help the design of new therapeutics against life-threatening diseases, according to the companies.


Copyright © 2020 scienceboard.net
 


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.